Search results
Results from the WOW.Com Content Network
The Brazilian Health Regulatory Agency (Portuguese: Agência Nacional de Vigilância Sanitária, Anvisa, literally National Health Surveillance Agency) is a regulatory body of the Brazilian government, created in 1999 during President Fernando Henrique Cardoso's term of office.
The Brazilian Controlled Drugs and Substances Act (Portuguese: Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial), officially Portaria nº 344/1998, [1] is Brazil's federal drug control statute, issued by the Ministry of Health through its National Health Surveillance Agency (Anvisa).
The Brazilian Nonproprietary Name or DCB, from the Portuguese Denominação Comum Brasileira is the official Portuguese nomenclature for drugs or active ingredients that have been approved by the Brazilian Health Regulatory Agency (ANVISA) for use in Brazil. [1] [2] The consolidated list from October 2021 contains just over 12,300 items. [3]
This is a list of organs of the federal government of Brazil that intend to regulate markets: Brazilian Electricity Regulatory Agency; Administrative Council for Economic Defense; National Health Surveillance Agency; Brazilian Agency of Telecommunications; National Agency of Petroleum, Natural Gas and Biofuels
The 2009 Brazilian Federal Law 11.903 and subsequent regulations of the National Agency for Sanitary Surveillance in Brazil (ANVISA) require that a 2D data matrix code be put on all secondary packaging. Under these provisions, manufacturers will be required to maintain a database of all transactions from manufacturing to dispensing, while ...
Language links are at the top of the page across from the title.
The Brazilian health system also provides free vaccines and medicines for people with various diseases (such as diabetes, high blood pressure, asthma, HIV and Alzheimer's), funds research in the area of epidemiology and monitors the quality of food offered in commercial establishments through the National Health Surveillance Agency (Anvisa).
Therapeutic goods in Brazil are regulated by the Ministry of Health of Brazil, through its Brazilian Health Regulatory Agency (Anvisa), equivalent to the US Food and Drug Administration. There are six main categories: [citation needed]